Prognostic value of the platelet to lymphocyte ratio change in liver cancer

Journal of Surgical Research

Volumn 194, Issue 2, 2015, Pages 464-470

  Peng, Wei ^a   Li, Chuan ^a   Zhu, Wen Jiang ^a   Wen, Tian Fu ^a   Yan, Lv Nan ^a   Li, Bo ^a   Wang, Wen Tao ^a   Yang, Jia Yin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Liver resection; Milan criteria; Platelet to lymphocyte ratio; Prognostic factor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PLATELET LYMPHOCYTE RATIO; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; BLOOD; CARCINOMA, HEPATOCELLULAR; CHINA; COMPLICATION; EPIDEMIOLOGY; HEPATITIS B; LIVER NEOPLASMS; LYMPHOCYTE COUNT; MIDDLE AGED; MORTALITY; PROGNOSIS; THROMBOCYTE COUNT; VIROLOGY; YOUNG ADULT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHINA; FEMALE; HEPATECTOMY; HEPATITIS B; HUMANS; LIVER NEOPLASMS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84924905240     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.12.021     Document Type: Article

References (36)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893
2. H.B. El-Serag Hepatocellular carcinoma N Engl J Med 365 2011 1118
3. A.P. Venook, C. Papandreou, J. Furuse, and L.L. de Guevara The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective Oncologist 15 2010 5
4. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693
5. W.R. Jarnagin Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation Ann Surg Oncol 17 2010 1226
6. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208
7. G. Ercolani, G.L. Grazi, and M. Ravaioli Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence Ann Surg 237 2003 536
8. I. Ikai, S. Arii, and M. Kojiro Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey Cancer 101 2004 796
9. C.N. Yeh, M.F.U. Chen, W.C. Lee, and L.B. Jeng Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis J Surg Oncol 81 2002 195
10. M. Kaibori, M. Ishizaki, T. Saito, K. Matsui, A.H. Kwon, and Y. Kamiyama Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas Am J Surg 198 2009 39
11. R.T. Poon, S.T. Fan, C.M. Lo, C.L. Liu, and J. Wong Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors Ann Surg 229 1999 216
12. K. Schutte, J. Bornschein, and P. Malfertheiner Hepatocellular carcinoma-epidemiological trends and risk factors Dig Dis 27 2009 80
13. H.R. Scott, D.C. McMillan, L.M. Forrest, D.J. Brown, C.S. McArdle, and R. Milroy The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer Br J Cancer 87 2002 264
14. D.C. McMillan, K. Canna, and C.S. McArdle Systemic inflammatory response predicts survival following curative resection of colorectal cancer Br J Surg 90 2003 215
15. M. Hilmy, J.M. Bartlett, M.A. Underwood, and D.C. McMillan The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder Br J Cancer 92 2005 625
16. D.J. Pinato, J. Stebbing, and M. Ishizuka A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI) J Hepatol 57 2012 1013
17. D.H. Esper, and W.A. Harb The cancer cachexia syndrome: a review of metabolic and clinical manifestations Nutr Clin Pract 20 2005 369
18. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860
19. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883
20. B.S. Oh, J.W. Jang, and J.H. Kwon Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma BMC Cancer 13 2013 78
21. S. Krenn-Pilko, U. Langsenlehner, and E.M. Thurner The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients Br J Cancer 110 2014 2524
22. A. Kinoshita, H. Onoda, and N. Imai Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma Br J Cancer 107 2012 988
23. Q. Lai, E. Castro Santa, J.M. Rico Juri, R.S. Pinheiro, and J. Lerut Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer Transpl Int 27 2014 32
24. S. Raungkaewmanee, S. Tangjitgamol, S. Manusirivithaya, S. Srijaipracharoen, and T. Thavaramara Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer J Gynecol Oncol 23 2012 265
25. J.F. Feng, Y. Huang, and Q.X. Chen Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma World J Surg Oncol 12 2014 58
26. X. Zhou, Y. Du, and Z. Huang Prognostic value of PLR in various cancers: a meta-analysis PLoS One 2014 10.1371/journal.pone.0101119
27. K. Yamamura, H. Sugimoto, and M. Kanda Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection J Hepatobiliary Pancreat Sci 21 2014 682
28. M. Aliustaoglu, A. Bilici, and M. Seker The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer Hepatogastroenterology 57 2010 640
29. S.L. Shen, S.J. Fu, and B. Chen Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection Ann Surg Oncol 2014 10.1245/s10434-014-3771-x
30. L.G. Guidotti, and F.V. Chisari Immunobiology and pathogenesis of viral hepatitis Annu Rev Pathol 1 2006 23
31. M. Iannacone, G. Sitia, and M. Isogawa Platelets mediate cytotoxic T lymphocyte-induced liver damage Nat Med 11 2005 1167
32. G. Sitia, R. Aiolfi, and P. Di Lucia Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B Proc Natl Acad Sci U S A 109 2012 E2165
33. N.M. Bambace, and C.E. Holmes The platelet contribution to cancer progression J Thromb Haemost 9 2011 237
34. Y.H. Kusumanto, W.A. Dam, G.A. Hospers, C. Meijer, and N.H. Mulder Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor Angiogenesis 6 2003 283
35. G.P. Dunn, L.J. Old, and R.D. Schreiber The immunobiology of cancer immunosurveillance and immunoediting Immunity 21 2004 137
36. P.R. Ding, X. An, and R.X. Zhang Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer Int J Colorectal Dis 25 2010 1427